Estonia’s LSMedical develops nanoparticle contrast agent for CT and MRI to target broader patient access
Estonian healthtech firm LSMedical is developing a nanoparticle contrast agent for both CT and MRI, targeting patients unsuited to current solutions, with clinical trials planned. [..]